Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art
- 11 July 2018
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 24 (13), 1405-1433
- https://doi.org/10.2174/1381612824666171218125431
Abstract
Background: Cyclodextrins (CDs) are versatile excipients with an essential role in drug delivery, as they can form non-covalently bonded inclusion complexes (host-guest complexes) with several drugs either in solution or in the solid state. Methods: The main purpose of this publication was to carry out a state of the art of CDs as complexing agents in drug carrier systems. In this way, the history, properties and pharmaceutical applications of the CDs were highlighted with typical examples. The methods to enhance the complexation efficiency (CE) and the CDs applications in solid dosage forms were emphasized in more detail. Results: The main advantages of using these cyclic oligosaccharides are as follows: (1) to enhance solubility/dissolution/ bioavailability of poorly soluble drugs; (2) to enhance drug stability; (3) to modify the drug release site and/or time profile; and (4) to reduce drug side effects (for example, gastric or ocular irritation). These compounds present favorable toxicological profile for human use and therefore there are various medicines containing CDs approved by regulatory authorities worldwide. On the other hand, the major drawback of CDs is the increase in formulation bulk, once the CE is, in general, very low. This aspect is particularly relevant in solid dosage forms and limits the use of CDs to potent drugs. Conclusion: CDs have great potential as drug carriers in Pharmaceutical Technology and can be used by the formulator in order to improve the drug properties such as solubility, bioavailability and stability. Additionally, recent studies have shown that these compounds can be applied as active pharmaceutical ingredients.Keywords
This publication has 230 references indexed in Scilit:
- Cyclodextrin-based nanosponges as drug carriersBeilstein Journal of Organic Chemistry, 2012
- Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCI Inclusion ComplexesJournal of Young Pharmacists, 2012
- Preparation, characterization and in vitro dissolution study of Nitrazepam: Cyclodextrin inclusion complexJournal of Pharmacy And Bioallied Sciences, 2012
- Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: Complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymerDrug Development and Industrial Pharmacy, 2011
- Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled ReleaseAAPS PharmSciTech, 2011
- Colon Targeted Drug Delivery Systems: A Review on Primary and Novel ApproachesOman Medical Journal, 2010
- Effect of Auxiliary Substances on Complexation Efficiency and Intrinsic Dissolution Rate of Gemfibrozil–β-CD ComplexesAAPS PharmSciTech, 2009
- Design and In Vitro Evaluation of Novel Sustained-Release Double-Layer Tablets of Lornoxicam: Utility of Cyclodextrin and Xanthan Gum CombinationAAPS PharmSciTech, 2009
- Studies on the Effect of Water-Soluble Polymers on Drug–Cyclodextrin Complex SolubilityAAPS PharmSciTech, 2009
- Quercetin/β-Cyclodextrin Solid Complexes Prepared in Aqueous Solution Followed by Spray-drying or by Physical MixtureAAPS PharmSciTech, 2009